Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEBO vs Lidocaine for Traumatic Oral Ulcer
NCT06184282Completed
- Sponsor
- October 6 University
- Start
- Jul 2023
- Primary completion
- Aug 2023
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Randomised, open-label trial of MEBO Moist Burn Ointment in traumatic oral ulcer (2 arms), sponsored by October 6 University. Primary endpoint: The degree of pain at 10 days. Started Jul 2023; status: completed.
02
Drugs
MEBO Moist Burn Ointment
03
Conditions
traumatic oral ulcer
Beyond the preview
Go deeper on NCT06184282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06184282.